NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PBHC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain quarterly dividend of $0.10 per share | A primary condition in Pathfinder Bancorp Inc's published investment case. The stated target is >= $0.10 per share quarterly. | Intact | Dividend per share falls below $0.10 in any quarter | Dividend per share: $0.10 per share FY2026-Q2; GAAP. Published target: >= $0.10 per share quarterly. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 13, 20260.1 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-bank earnings and sector-sensitive thesis, rather than a clear durable growth story. The signal has shifted from cautious to mixed, but the thesis remains on watch because recent financial performance trails its industry cohort.
PBHC is described as cheap versus peers, with a negative expectations gap, meaning current expectations appear below the model’s view. Pricing is tagged as justified and fragility is low, but valuation evidence has only medium confidence and does not remove the business risks.
Near term, management’s focus on consistent 2026 earnings is on track: net income and revenue rose from Q1 to Q2, while the company continued its quarterly dividend. Core deposits and commercial loans declined over that period, and recent financial performance remains weak relative to the industry cohort.
The multi-year thesis depends on whether earnings consistency continues while deposits and commercial lending stabilize or grow. A guidance cut would be a meaningful negative, and rate cuts could weigh on the sector; continued strong results and guidance from sector bellwethers would support sector momentum.
Over the next 1 to 3 years, PBHC combines peer-relative cheapness with improving recent earnings, but the thesis remains uncertain until its funding and lending trends improve and relative performance strengthens. The evidence supports a watchful, mixed view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 3 supplied quarters. Management reported: “• Quarterly cash dividends payable to common stockholders of $0.10 per share were declared on September 28, 2026 and are payable on November 6, 2026.” “• Quarterly cash dividends payable to common stockholders of $0.10 per share were declared on June 29, 2026 and are payable on August 7, 2026.”
Delivery assessment Nov 4, 2026Generate consistent positive earnings | A primary condition in Pathfinder Bancorp Inc's published investment case. The stated target is Net income > 0 for at least 3 consecutive quarters. | Improving | Net income falls below zero for 2 consecutive quarters | Net income: $2.668M FY2026-Q2; GAAP. Published target: Net income > 0 for at least 3 consecutive quarters. Target period is not explicitly aligned with this observation. Aug 13, 20262,668,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth around 2% annually | A supporting condition in Pathfinder Bancorp Inc's published investment case. The stated target is >= 2% YoY revenue growth. | Intact | Revenue growth falls below 1% YoY | Revenue growth: -5.81% FY2026-Q2; GAAP. Published target: >= 2% YoY revenue growth. Annual target cannot be compared with a quarterly or TTM observation. Aug 13, 2026-5.807528 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.